MENU
LGND
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ligand Pharmaceuticals (LGND) Earnings Date & Reports
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
LGND is expected to report earnings to fall 2.11% to $2.32 per share on November 05
Q3'26
Est.
$2.32
Q2'26
Beat
by $0.42
Q1'26
Missed
by $0.21
Q4'25
Beat
by $0.53
Q3'25
Beat
by $1.16
The last earnings report on August 06 showed earnings per share of $2.37, beating the estimate of $1.95. With 118.27K shares outstanding, the current market capitalization sits at 5.67B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
47
Web
https://www.ligand.com